(Q38364911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1 reference

D Chihara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J E Romaguera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

N H Fowler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J F Seymour

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

F B Hagemeister

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M L Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

23 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1175-1179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25712454%20AND%20SRC:MED&resulttype=core&format=json

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Treatment of older patients with mantle-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111

Analysis of the coding genome of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV111